Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
Mayo Clinic
Roswell Park Cancer Institute
Hoffmann-La Roche
ViroMissile, Inc.
Arcus Biosciences, Inc.
Bristol-Myers Squibb
Duke University
Tizona Therapeutics, Inc
A2 Biotherapeutics Inc.
Canadian Cancer Trials Group
Wake Forest University Health Sciences
Poseida Therapeutics, Inc.
MacroGenics
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
NRG Oncology
Ocellaris Pharma, Inc.
Novartis
Mayo Clinic
GlaxoSmithKline
Memorial Sloan Kettering Cancer Center
NeoTX Therapeutics Ltd.
OncoHost Ltd.
Bolt Biotherapeutics, Inc.
Nanobiotix
ITM Oncologics GmbH
Actym Therapeutics, Inc.
Janux Therapeutics
Sichuan Baili Pharmaceutical Co., Ltd.
Scancell Ltd
Travera Inc
A2 Biotherapeutics Inc.
Exelixis
Incyte Corporation
Jonsson Comprehensive Cancer Center
Xencor, Inc.
Numab Therapeutics AG
NuCana plc
A2 Biotherapeutics Inc.
Medicenna Therapeutics, Inc.
NextPoint Therapeutics, Inc.
NRG Oncology
UNICANCER
Merus B.V.
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano